1-3 of 3
Luis Lopez Lazaro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Pharmacokinetics and Pharmacodynamics of Two Anti-CD20 Monoclonal Antibodies (Candidate Biosimilar DRL-Rituximab and Innovator Reference Product Rituximab (Mabthera®) in a Randomised, Multi-Centre, Double-Blind, Parallel Group Study of CHOP with Rituximab Chemotherapy in Patients with CD20-Positive Diffuse Large B-Cell Lymphoma

Auro Viswabandya, Asis Mukhopadhyay, Sandip Shah, Rajnish Vasant Nagarkar, Sonica Sachdeva Batra, Luis Lopez Lazaro, Suresh Kankanwadi, Alok Srivastava
Journal: Blood
Blood (2016) 128 (22): 5391.
https://doi.org/10.1182/blood.V128.22.5391.5391
Published: 2016
Journal Articles

GlycoPEGylated Filgrastim XM22 Demonstrates Dose-Dependent Activity in Comparison to Pegfilgrastim in a Dose-Escalating Study in Healthy Volunteers after Body-Weight Dependent Single Dose.

Heinz Lubenau, PhD, Rolf Pokorny, MD, Luis Lopez-Lazaro, MD, Peter Bias, MD, Bruce Wallin, MD, Walter Hinderer, PhD, Anne-Katrin Maly, Michael Seiberling, MD
Journal: Blood
Blood (2007) 110 (11): 4081.
https://doi.org/10.1182/blood.V110.11.4081.4081
Published: 2007
Journal Articles

GlycoPEGylated Filgrastim XM22 Fixed Dose Demonstrates Similar Activity in Comparison to Pegfilgrastim in Healthy Volunteers after Single Administration.

Heinz Lubenau, PhD, Rolf Pokorny, MD, Luis Lopez-Lazaro, MD, Peter Bias, MD, Bruce Wallin, MD, Walter Hinderer, PhD, Anne-Katrin Maly, Michael Seiberling, MD
Journal: Blood
Blood (2007) 110 (11): 4082.
https://doi.org/10.1182/blood.V110.11.4082.4082
Published: 2007